Campbell, CA, United States of America

Cyril De Colle

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Cyril De Colle

Introduction

Cyril De Colle is a notable inventor based in Campbell, CA (US). He has made significant contributions to the field of medical treatments, particularly focusing on gastrointestinal disorders. With a total of 4 patents, his work has the potential to impact many lives.

Latest Patents

Cyril's latest patents include innovative methods for treating gastrointestinal (GI) tract disorders. One of his patents outlines methods, compositions, and kits for the treatment of an enteric nervous system disorder. These methods may involve administering an effective amount of a phenothiazine compound, a peripherally restricted dopamine decarboxylase inhibitor, and/or a peripherally restricted dopamine D2 receptor antagonist that does not substantially inhibit hERG channels. Another patent focuses on prodrugs of metopimazine, providing similar methods and compositions for treating enteric nervous system disorders.

Career Highlights

Cyril De Colle has established himself as a key figure in the medical innovation landscape. His work at Neurogastrx, Inc. has allowed him to explore and develop groundbreaking treatments that address complex health issues. His dedication to improving patient outcomes is evident in his research and patent filings.

Collaborations

Cyril has collaborated with esteemed colleagues such as Pankaj Jay Pasricha and David Juergen Wustrow. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.

Conclusion

Cyril De Colle's contributions to medical innovation, particularly in treating gastrointestinal disorders, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…